Skip to content

Biophysical Methods: Spectroscopy, Structure Determination, Mass Spectrometry and SPR

UV-vis, fluorescence, FRET, CD, NMR, ESR, X-ray, cryo-EM, light scattering, mass spectrometry and SPR, with worked numericals for CSIR NET Life Sciences.

  • 20 min read
  • Updated
On this page · 20 sections
  1. Prerequisites
  2. The Hook: Same Protein, Seven Instruments
  3. Choosing the Method
  4. UV-Visible Absorption
  5. Fluorescence
  6. Circular Dichroism (CD)
  7. NMR Spectroscopy
  8. ESR (EPR) Spectroscopy
  9. X-ray Diffraction
  10. Cryo-Electron Microscopy
  11. Light Scattering
  12. Mass Spectrometry
  13. Surface Plasmon Resonance (SPR)
  14. Memory Tricks
  15. Don’t Confuse
  16. Common Mistakes
  17. Practice
  18. Quick Revision Table
  19. Key Takeaways
  20. What’s Next

Prerequisites

The Hook: Same Protein, Seven Instruments

How CSIR NET asks it. Part B: which technique detects unpaired electrons, which needs crystals, what a 222 nm CD minimum means, which ionisation gives multiply charged ions, which nuclei are NMR-active. Part C: Beer–Lambert concentrations, FRET distances, ESI charge-state deconvolution, KD from SPR rate constants, Stokes–Einstein radii, and interpreting denaturation curves from two probes.


Choosing the Method

QuestionMethod(s)Signal
Concentration, purityUV-vis absorbanceA₂₈₀ (aromatics), A₂₆₀ (bases)
Local environment, binding, distances 2–10 nmFluorescence, FRET, anisotropyEmitted light
Secondary structure, foldingCD (far-UV)Differential absorption of circularly polarised light
Atomic structure in solution, dynamicsNMRNuclear spin transitions
Unpaired electrons, radicals, metal centres, spin-label distancesESR / EPRElectron spin transitions
Atomic structure from crystalsX-ray diffractionDiffracted X-rays (Bragg)
Structure of large complexes without crystalsCryo-EMElectron images of vitrified particles
Size, aggregation, absolute massLight scattering (DLS, SLS/MALS)Scattered light
Exact mass, sequence, PTMsMass spectrometrym/z of ions
Binding kinetics, label-freeSPRRefractive-index change at a gold surface

UV-Visible Absorption

Beer–Lambert law:

$$A = \log_{10}\frac{I_0}{I} = \varepsilon\, c\, l$$

A is dimensionless, ε is the molar absorption coefficient (M⁻¹ cm⁻¹), c in M, l in cm. Linear only at low absorbance (roughly below 1–1.5), in the absence of scattering.

ChromophoreλmaxUse
Trp (ε₂₈₀ about 5,500 M⁻¹ cm⁻¹), Tyr (about 1,490), cystine (about 125)280 nmProtein concentration from sequence: ε₂₈₀ = 5,500 nW + 1,490 nY + 125 nC (Pace values)
Peptide bondabout 190–220 nmVery sensitive, but buffers interfere
Nucleic acid bases260 nmA₂₆₀ = 1 ↔ 50 µg/mL dsDNA; hyperchromic on melting
NADH / NADPH340 nm (ε = 6,220 M⁻¹ cm⁻¹); NAD⁺ does not absorb thereContinuous dehydrogenase assays
Haem (Soret band)about 410–420 nmHaemoproteins, cytochromes
  • Hyperchromic effect: single-stranded DNA absorbs more at 260 nm than duplex because base stacking is lost; melting curves follow A₂₆₀.
  • Colorimetric protein assays: Bradford (Coomassie G-250 binding, shift to 595 nm), BCA and Lowry (Cu²⁺ reduction), biuret (peptide bonds). Each depends on composition; calibrate with a standard such as BSA.
  • Turbidity is scattering, not absorption: OD₆₀₀ of a bacterial culture measures light scattered away from the detector.

Fluorescence

A molecule absorbs a photon (S₀ → S₁, femtoseconds), relaxes vibrationally, and emits from the lowest level of S₁ (nanoseconds). Hence:

  • Stokes shift: emission at longer wavelength than excitation.
  • Quantum yield Φ = photons emitted / photons absorbed; lifetime τ typically ns.
  • Intersystem crossing to the triplet state gives slow phosphorescence.
  • Far more sensitive than absorbance (signal against a dark background).

Intrinsic probes

  • Trp dominates protein fluorescence. Excite at 295 nm to excite Trp selectively (Tyr absorbs little there). Emission maximum about 350 nm when exposed to water; blue-shifted (towards about 330 nm) when buried in a non-polar interior. Unfolding gives a red shift and usually an intensity change.
  • Extrinsic dyes: ANS (fluoresces when bound to exposed hydrophobic patches, used for molten globules), fluorescein, rhodamine, cyanines; GFP and its variants for live cells (its chromophore forms autocatalytically from Ser65–Tyr66–Gly67).

Quenching

Stern–Volmer: \(\dfrac{F_0}{F} = 1 + K_{SV}[Q]\), with \(K_{SV} = k_q\tau_0\).

  • Dynamic (collisional) quenching shortens the lifetime; increases with temperature (faster diffusion).
  • Static quenching (a non-fluorescent ground-state complex) leaves the lifetime of the remaining fluorophores unchanged; decreases with temperature (complex dissociates).
  • Acrylamide or iodide accessibility tells whether a Trp is surface-exposed.

FRET (Förster resonance energy transfer)

Non-radiative dipole–dipole transfer from an excited donor to an acceptor whose absorption overlaps the donor emission.

$$E = \frac{1}{1 + (r/R_0)^6} \qquad E = 1 - \frac{F_{DA}}{F_D}$$
  • R₀ (Förster distance) is the distance at which E = 50%; typically a few nm (often quoted 2–6 nm for common pairs). Depends on spectral overlap, donor quantum yield, refractive index and orientation factor κ².
  • The sixth-power dependence makes FRET a “spectroscopic ruler”: E falls from 98% at 0.5 R₀ to 1.5% at 2 R₀.
  • Uses: conformational change, protein–protein interaction, biosensors (CFP–YFP pairs), single-molecule FRET.

Anisotropy and other fluorescence methods

  • Fluorescence anisotropy / polarisation: excite with polarised light; a small, fast-tumbling fluorophore depolarises emission. Binding to a large protein slows tumbling and raises anisotropy, a standard binding assay.
  • FRAP (fluorescence recovery after photobleaching) measures lateral mobility; FCS (correlation spectroscopy) measures diffusion and concentration from fluctuations.

Circular Dichroism (CD)

CD is the difference in absorption of left- and right-circularly polarised light, \(\Delta A = A_L - A_R\), by a chiral chromophore or a chromophore in a chiral environment. Reported as ellipticity θ, usually normalised to mean residue ellipticity (deg cm² dmol⁻¹).

RegionChromophoreInformation
Far-UV (about 180–250 nm)Peptide bondSecondary structure
Near-UV (about 250–320 nm)Trp, Tyr, Phe, disulfidesTertiary structure fingerprint
VisibleBound cofactors (haem, flavin)Cofactor environment
StructureFar-UV CD signature
α-helixNegative bands at 222 and 208 nm, strong positive near 190–193 nm
β-sheetSingle negative band near 216–218 nm, positive near 195 nm
Random coilStrong negative band near 195–200 nm
  • Unfolding is followed at 222 nm against temperature or denaturant. A molten globule keeps far-UV CD (secondary structure) but loses near-UV CD (fixed tertiary packing).
  • Nucleic acids: B-DNA shows a positive band near 275 nm and a negative band near 245 nm; Z-DNA gives a nearly inverted spectrum, the classic CD evidence for the B → Z transition.
  • CD needs no crystals and little sample, but gives average secondary-structure content, not where the helices are.

NMR Spectroscopy

Nuclei with non-zero spin (I = ½ is simplest: ¹H, ¹³C, ¹⁵N, ³¹P, ¹⁹F) placed in a magnetic field B₀ split into energy levels; transitions occur at the Larmor frequency \(\nu = \gamma B_0/2\pi\). A “600 MHz” spectrometer is one where ¹H resonates at 600 MHz (about 14.1 T). ¹²C and ¹⁶O (I = 0) are NMR-silent, which is why proteins are labelled with ¹³C and ¹⁵N.

ParameterMeaning
Chemical shift δ (ppm)\((\nu - \nu_{ref})/\nu_{ref} \times 10^6\); reports the electronic environment; referenced to TMS/DSS
J-couplingThrough-bond splitting (few bonds); gives dihedral angles (Karplus relation)
NOEThrough-space dipolar transfer, ∝ r⁻⁶, detectable up to about 5–6 Å: the distance restraints for structure
Relaxation (T₁, T₂)Dynamics; large molecules tumble slowly, T₂ shortens, lines broaden
ExperimentCorrelates
COSY¹H–¹H through 2–3 bonds
TOCSYAll ¹H in one spin system (one residue)
NOESY¹H–¹H through space (< about 5 Å)
¹H–¹⁵N HSQCEach backbone N–H: one peak per non-proline residue (the protein’s “fingerprint”)
Triple-resonance (HNCA, HNCACB…)Backbone assignment in ¹³C/¹⁵N-labelled protein
  • Strengths: structure in solution, dynamics from ps to s, binding-site mapping by chemical-shift perturbation, H/D exchange, intrinsically disordered proteins.
  • Limits: line broadening with size; conventional solution NMR is easiest for proteins up to a few tens of kDa. Deuteration and TROSY extend the range. Solid-state NMR handles membrane proteins and amyloid fibrils.
  • Kurt Wüthrich shared the 2002 Nobel Prize in Chemistry for protein structure determination by NMR.

ESR (EPR) Spectroscopy

Electron spin resonance detects unpaired electrons. Resonance condition:

$$h\nu = g\,\mu_B\,B$$

g ≈ 2.0023 for a free electron; deviations and hyperfine splitting (coupling to nearby nuclear spins) identify the species. Spectrometers commonly operate at X-band (about 9–10 GHz).

  • Detects: free radicals (tyrosyl radical of ribonucleotide reductase, semiquinones), paramagnetic metal centres (Cu²⁺, Fe³⁺, Mn²⁺, reduced Fe–S clusters, Mo⁵⁺).
  • ESR-silent: diamagnetic species (Zn²⁺, d¹⁰; most organic molecules) unless labelled.
  • Site-directed spin labelling: introduce a Cys, attach a nitroxide label (e.g. MTSL); the ¹⁴N hyperfine gives a three-line spectrum whose shape reports local mobility. DEER/PELDOR (pulsed) measures distances between two labels in the nanometre range.
  • Spin trapping (e.g. DMPO) turns short-lived reactive oxygen radicals into detectable adducts.

X-ray Diffraction

X-rays (wavelength around 1 Å, e.g. Cu Kα 1.54 Å or tunable synchrotron radiation) are scattered by electrons; a crystal’s regular lattice gives discrete reflections obeying Bragg’s law:

$$n\lambda = 2d\sin\theta$$

Workflow: purify → crystallise (vapour diffusion, hanging or sitting drop) → collect diffraction (intensities only) → solve the phase problem → build into the electron-density map → refine.

Phasing methodHow
Molecular replacementUse a homologous known structure as a search model
MIR / SIRHeavy-atom soaks (Hg, Pt, Au) change intensities
MAD / SADAnomalous scattering, often from selenomethionine-labelled protein
  • Resolution (in Å): smaller is better; around 1.5–2 Å shows side chains clearly; hydrogens are usually invisible except at very high resolution.
  • Quality: R-factor and the cross-validated R_free; B-factors report atomic displacement (mobility or disorder).
  • Limitations: needs crystals; crystal packing can bias flexible regions; a static, averaged picture.
  • Fibre diffraction of oriented fibres gave the helical “X” pattern of B-DNA (Franklin and Gosling’s photograph). SAXS (small-angle scattering) gives low-resolution shape in solution.

Cryo-Electron Microscopy

  • Sample in a thin film is plunge-frozen in liquid ethane so water forms vitreous (amorphous) ice, preserving native structure without stain or crystals.
  • Single-particle analysis: thousands to millions of particle images in random orientations, recorded at low electron dose on direct electron detectors → 2-D classification → 3-D reconstruction → refinement. Images are corrected for the contrast transfer function (CTF).
  • Resolution is judged by Fourier shell correlation, commonly at the 0.143 threshold; near-atomic maps are now routine for large complexes.
  • Advantages: no crystals; large, flexible, membrane complexes (ribosomes, spliceosome, channels); classification separates multiple conformations from one sample.
  • Cryo-electron tomography images cells or thin lamellae from a tilt series; subtomogram averaging improves resolution in situ.
  • The 2017 Nobel Prize in Chemistry (Dubochet, Frank, Henderson) recognised cryo-EM. Negative staining (heavy-metal salt) is a quick, low-resolution screen. Electron microscopy hardware is covered under microscopy.

Light Scattering

MethodMeasuresGives
Static (SLS), multi-angle (MALS)Time-averaged scattered intensity vs angle and concentrationAbsolute molar mass (Zimm analysis), radius of gyration; SEC-MALS gives mass independent of shape or column calibration
Dynamic (DLS)Intensity fluctuations (Brownian motion) → autocorrelationDiffusion coefficient D → hydrodynamic radius Rh, polydispersity

Stokes–Einstein:

$$R_h = \frac{k_B T}{6\pi\eta D}$$
  • Scattered intensity of small particles rises steeply with size (Rayleigh regime, proportional to the sixth power of diameter), so a trace of aggregate dominates a DLS signal: DLS is the standard aggregation check before crystallisation or cryo-EM.
  • Rayleigh scattering also scales as 1/λ⁴, which is why scattering artefacts grow at short wavelengths in UV and CD spectra.

Mass Spectrometry

A mass spectrometer has an ion source, a mass analyser (separates by m/z) and a detector.

Ion sourceKey features
ESI (electrospray ionisation)From solution; soft; multiply charged ions [M + nH]ⁿ⁺; couples directly to LC (LC-MS/MS)
MALDI (matrix-assisted laser desorption/ionisation)Sample co-crystallised with a UV-absorbing matrix (e.g. sinapinic acid, CHCA); laser pulse; mostly singly charged ions; pairs with TOF; fast fingerprinting, imaging MS
EI (electron impact)Hard ionisation, extensive fragmentation; small volatile molecules, GC-MS

The 2002 Nobel Prize in Chemistry was shared by Fenn (ESI) and Tanaka (soft laser desorption) with Wüthrich (NMR).

AnalyserPrincipleNote
TOFSame kinetic energy; flight time ∝ √(m/z)High mass range
QuadrupoleOscillating fields pass only one m/zMass filter; triple-quad for targeted quantitation
Ion trap / OrbitrapIon trap: ions held in RF fields and ejected in order of m/z; Orbitrap: frequency of axial oscillation gives m/zOrbitrap: very high resolution and accuracy
FT-ICRCyclotron frequency in a strong magnetHighest resolution

ESI charge-state arithmetic

For a protein of mass M carrying n protons (proton mass about 1.007 Da):

$$\frac{m}{z} = \frac{M + n(1.007)}{n}$$

Two adjacent peaks, \(p_1\) (higher m/z, charge n) and \(p_2\) (lower m/z, charge n + 1), give

$$n = \frac{p_2 - 1.007}{p_1 - p_2}, \qquad M = n(p_1 - 1.007)$$

Isotope spacing gives charge directly: peaks 1 Da apart → 1+, 0.5 apart → 2+, 0.25 apart → 4+.

Tandem MS and proteins

  • MS/MS: select a precursor ion, fragment it (e.g. collision-induced dissociation), measure fragments. Peptide backbone cleavage gives b ions (N-terminal) and y ions (C-terminal); mass differences between consecutive ions identify residues.
  • Leu and Ile have identical mass; standard MS/MS cannot tell them apart.
  • Peptide mass fingerprinting: digest with trypsin (cleaves after Lys/Arg, not before Pro), match peptide masses to a database.
  • Also: PTM mapping (phosphorylation +80 Da), native MS of intact complexes, HDX-MS for dynamics, cross-linking MS. Proteomics workflows are on the omics page.

Surface Plasmon Resonance (SPR)

  • Polarised light undergoes total internal reflection at a glass–gold film interface; at one angle it excites surface plasmons and reflected intensity dips. The evanescent field probes about a few hundred nm into the solution side, so the resonance angle shifts when mass binds to the surface (refractive-index change).
  • One partner (ligand) is immobilised on the sensor chip; the other (analyte) flows over it. Signal in response units (RU); label-free and real time.
  • Sensorgram: baseline → association (analyte flowing) → dissociation (buffer flowing) → regeneration.
$$K_D = \frac{k_d}{k_a}, \qquad t_{1/2}(\text{complex}) = \frac{0.693}{k_d}$$

with \(k_a\) in M⁻¹ s⁻¹ and \(k_d\) in s⁻¹. Two drugs with the same KD can differ a hundredfold in residence time, which SPR reveals and equilibrium methods do not.

  • Pitfalls: mass-transport limitation, non-specific binding to the reference surface, immobilisation that blocks the binding site. Bio-layer interferometry is a related label-free method; isothermal titration calorimetry gives KD, ΔH and stoichiometry from heat but no rates.

Memory Tricks

  • FRET sixth power: at R₀, 50%; at half R₀, 98%; at twice R₀, 1.5%.
  • Crystals only for X-ray: NMR needs a concentrated solution, cryo-EM needs vitreous ice, X-ray needs a crystal.

Don’t Confuse

ThisvsThat
Absorbance (Beer–Lambert, A₂₈₀)vsFluorescence (emission, Stokes-shifted, far more sensitive)
Far-UV CD: secondary structurevsNear-UV CD: tertiary environment of aromatics
NMR: nuclear spins, solution structurevsESR: unpaired electrons, radicals and metals
NOE: through space, ∝ r⁻⁶vsJ-coupling: through bonds
X-ray: crystals, electron density, phase problemvsCryo-EM: vitrified particles, Coulomb potential maps, no crystals
DLS: diffusion → hydrodynamic radiusvsSLS/MALS: intensity → absolute mass
ESI: multiply charged, LC-coupledvsMALDI: singly charged, TOF, matrix
b ions: N-terminal fragmentsvsy ions: C-terminal fragments
SPR: kinetics (ka, kd) and KDvsITC: KD, ΔH, n from heat; no rates
Dynamic quenching: lifetime fallsvsStatic quenching: lifetime unchanged

Common Mistakes


Practice

All questions below are original practice questions written in CSIR NET style. They are not previous-year questions.

Level 1: Foundation

  1. Which spectroscopic technique gives a negative band at 222 nm for an α-helical protein?
  2. Name one technique that requires a crystal and one that does not but still gives near-atomic structures of large complexes.
  3. Which ionisation method gives an envelope of multiply charged ions?
Answers
  1. Far-UV circular dichroism.
  2. X-ray crystallography requires crystals; single-particle cryo-EM does not.
  3. Electrospray ionisation (ESI).

Level 2: Part B Style

Q1 (practice). A protein contains 2 Trp, 4 Tyr and 1 disulfide bond. Its A₂₈₀ in a 1 cm cuvette is 0.427. Using ε(Trp) = 5,500, ε(Tyr) = 1,490 and ε(cystine) = 125 M⁻¹ cm⁻¹, its concentration is about:

  • (a) 2.5 µM
  • (b) 25 µM
  • (c) 78 µM
  • (d) 250 µM
Answer and explanation

(b). ε₂₈₀ = 2(5,500) + 4(1,490) + 125 = 17,085 M⁻¹ cm⁻¹. c = A/(εl) = 0.427/17,085 = 2.5 × 10⁻⁵ M = 25 µM.

Q2 (practice). A donor–acceptor pair has R₀ = 5 nm. If the distance between them increases from 5 nm to 10 nm, the FRET efficiency changes from:

  • (a) 50% to 25%
  • (b) 50% to about 1.5%
  • (c) 100% to 50%
  • (d) 50% to about 12.5%
Answer and explanation

(b). At r = R₀, E = 0.5. At r = 2R₀, E = 1/(1 + 2⁶) = 1/65 ≈ 0.015. The sixth-power dependence makes FRET fall off sharply.

Q3 (practice). An ESI spectrum of a protein shows two adjacent peaks at m/z 1091.9 and 1001.0. Taking the proton mass as 1.007 Da, the charge on the 1091.9 peak and the protein mass are:

  • (a) 10+ and 10.9 kDa
  • (b) 11+ and 12.0 kDa
  • (c) 12+ and 13.1 kDa
  • (d) 11+ and 11.0 kDa
Answer and explanation

(b). \(n = (1001.0 - 1.007)/(1091.9 - 1001.0) = 999.99/90.9 = 11.0\). \(M = 11 \times (1091.9 - 1.007) = 11 \times 1090.89 \approx 12{,}000\) Da. Check: the 1001.0 peak is 12+: (12,000 + 12 × 1.007)/12 = 1001.0.

Q4 (practice). A uniformly ¹⁵N-labelled protein of 120 residues contains 6 prolines, none at the N-terminus. Ignoring side-chain NH groups, the maximum number of backbone amide peaks expected in its ¹H–¹⁵N HSQC spectrum is:

  • (a) 120
  • (b) 119
  • (c) 114
  • (d) 113
Answer and explanation

(d). Prolines (6) have no amide H. The N-terminal residue carries a free NH₃⁺ that exchanges rapidly with water and is normally not seen. 120 − 6 − 1 = 113. Asn/Gln side-chain NH₂ and Trp indole NH give extra peaks, which is why the question excludes them.

Level 3: Part C Style

Q1 (practice). A kinase is characterised before a drug-binding study.

  • DLS at 25 °C (298 K, η = 0.89 mPa s) gives a single population with D = 6.0 × 10⁻¹¹ m² s⁻¹.
  • SPR with the kinase immobilised: inhibitor X has kₐ = 2 × 10⁵ M⁻¹ s⁻¹ and k_d = 4 × 10⁻³ s⁻¹; inhibitor Y has kₐ = 2 × 10³ M⁻¹ s⁻¹ and k_d = 4 × 10⁻⁵ s⁻¹.

(i) Calculate Rh. (ii) Calculate KD for X and Y. (iii) Which inhibitor has the longer residence time, and by how much?

Answer and worked solution
  1. \(R_h = \dfrac{k_BT}{6\pi\eta D} = \dfrac{(1.381\times10^{-23})(298)}{6\pi(0.89\times10^{-3})(6.0\times10^{-11})} \approx 4.1\times10^{-9}\) m = 4.1 nm, a size typical of a globular protein of a few tens of kDa; a single population means no large aggregates.
  2. KD(X) = 4 × 10⁻³ / 2 × 10⁵ = 2 × 10⁻⁸ M (20 nM). KD(Y) = 4 × 10⁻⁵ / 2 × 10³ = 2 × 10⁻⁸ M (20 nM). Same affinity.
  3. Complex half-life = 0.693/k_d: X about 173 s; Y about 17,300 s (about 4.8 h). Y stays bound 100 times longer. Equilibrium methods would rate the two drugs as equal; SPR separates them by kinetics.

Q2 (practice). A single-domain protein is titrated with urea and followed by two probes: far-UV CD at 222 nm and Trp fluorescence (emission maximum). The fluorescence transition midpoint is 2.5 M urea; the CD midpoint is 4.0 M urea. At 3 M urea, the Trp emission maximum has already shifted from 332 nm (native) to 350 nm, while about 80% of the 222 nm signal remains.

Which statements are correct?

(A) The protein does not unfold by a simple two-state mechanism. (B) An intermediate with native-like secondary structure but disrupted tertiary packing is populated. (C) The red shift shows the Trp becoming buried as urea increases. (D) Near-UV CD would be expected to change at lower urea than far-UV CD.

  • (a) A, B and D
  • (b) A and C only
  • (c) B and C only
  • (d) A, B, C and D
Answer and worked solution

(a) A, B and D.

  • (A) For a two-state process, all probes give the same transition midpoint. Different midpoints (2.5 vs 4.0 M) mean at least one intermediate.
  • (B) At 3 M urea, secondary structure is largely intact (CD) but the Trp is water-exposed (fluorescence): a molten-globule-like intermediate.
  • (C) Wrong: a red shift means the Trp is moving into water, i.e. becoming exposed.
  • (D) Near-UV CD reports fixed aromatic packing (tertiary structure), so it should track the fluorescence change, earlier than far-UV CD.

Q3 (practice). A protein is labelled with a donor at residue 20 and an acceptor at residue 150 (R₀ = 5.0 nm). Without ligand, the donor intensity falls from 100 (donor alone) to 80 (with acceptor). With ligand bound, it falls from 100 to 50. Calculate the donor–acceptor distance in each state and state what the ligand does.

Answer and worked solution
  1. E = 1 − F_DA/F_D. No ligand: E = 1 − 80/100 = 0.20. With ligand: E = 1 − 50/100 = 0.50.
  2. \(r = R_0\,(1/E - 1)^{1/6}\).
    • No ligand: r = 5.0 × (4)^(1/6) = 5.0 × 1.26 = 6.3 nm.
    • With ligand: r = 5.0 × (1)^(1/6) = 5.0 nm.
  3. Ligand binding brings the two sites about 1.3 nm closer, a closing conformational change (as in domain-closure of kinases or hinge-bending enzymes). Assumption: κ² and the donor quantum yield do not change on binding; a control is to check donor lifetime or use a second label pair.

Quick Revision Table

ItemFact
Beer–LambertA = εcl; ε₂₈₀ = 5,500 Trp + 1,490 Tyr + 125 cystine
NADH340 nm, ε = 6,220 M⁻¹ cm⁻¹
Trp fluorescenceExcite 295 nm; λmax about 350 nm exposed, blue-shifted when buried
Stern–VolmerF₀/F = 1 + K_SV[Q]; dynamic shortens τ
FRETE = 1/(1 + (r/R₀)⁶); E = 1 − F_DA/F_D
AnisotropyRises on binding to a larger partner
CD α / β / coil208 + 222 (−) / 218 (−) / about 198 (−)
Molten globuleFar-UV CD kept, near-UV CD lost, ANS binds
NMR-active¹H, ¹³C, ¹⁵N, ³¹P, ¹⁹F (I = ½); ¹²C, ¹⁶O silent
NOE∝ r⁻⁶; up to about 5–6 Å; distance restraints
HSQCOne peak per non-Pro backbone NH
ESRhν = gμ_B B; unpaired electrons; nitroxide spin labels; DEER distances
X-raynλ = 2d sin θ; phase problem (MR, MIR, MAD/SAD with SeMet); R_free
Cryo-EMVitreous ice, single-particle, FSC 0.143, Nobel 2017
DLS / SLSRh = k_BT/6πηD / absolute mass (MALS)
ESIn = (p₂ − 1.007)/(p₁ − p₂); M = n(p₁ − 1.007)
MALDIMatrix, laser, singly charged, TOF
MS/MSCID; b (N-term) and y (C-term) ions; Leu = Ile in mass
SPRGold film, evanescent wave, RU; KD = k_d/k_a; t½ = 0.693/k_d

Key Takeaways

What’s Next